This article describes the information currently available in the National Nutrition Monitoring System that is relevant to assessing the vitamin D status of US population groups, the strengths and limita- 
INTRODUCTION
The purpose of this article is to describe the availability of data for assessing the vitamin D nutritional status of US population groups and selected results of vitamin D status assessments by using data from the National Nutrition Monitoring System (NNMS). Surveys and related databases in the NNMS provide information about the nutrition-related health status of Americans over time and reference information on the nutrient composition of foods and dietary supplements (1) . Shown in Table 1 is relevant vitamin D information collected by the National Health and Nutrition Examination Survey (NHANES) conducted by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC; [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , the National Nutrient Database for Standard Reference (NNDB When using national databases, documentation of data quality and interpretability of nutritional variables are critical issues (1, 13, 16 -18) . In addition, for NHANES and other national surveys, the ability to obtain meaningful results depends on the use of statistical software to address the complex sampling designs (16, 17) . Statistical adjustments for converting data from dietary recalls into usual intakes are also necessary to avoid misleading the users of the data by providing inflated estimates at the tails of the distribution curves (19) .
VITAMIN D INTAKES
Intake estimations require information on the vitamin D content of foods and supplements and the frequency, types, and amounts of foods and supplements consumed.
Vitamin D content of foods
The USDA first published data on the vitamin D content of foods in a provisional table in 1991 and issued updates in 1999 (20) The ready-to-eat cereal labels did not specify the form of added vitamin D. Levels of vitamin D ranged from 1 g (40 IU) per regulatory serving for ready-to-eat cereals and cheeses to 1.5 g (60 IU) for spreads and 2.5 g (100 IU) for fluid milks. Several food categories (eg, juices and drinks, milk substitutes, and yogurts) had within-category ranges of 1 to 2.5 g (40 to 100 IU) of vitamin D per regulatory serving.
Human milk or commercial infant formula constitutes the sole source of nutrition for the first few months of life. On average, human milk contains Ȃ0.14 g (5.7 IU) vitamin D 3 per 100 kcal (22) . However, its biological activity is higher than the analyzed values indicate because human milk contains 25-hydroxyvitamin D [25(OH)D] in addition to vitamin D 3 (23) , and the analyzed value does not include the 25(OH)D content. In addition, the biological activity of 25(OH)D is higher than that of vitamin D. Commercial infant formulas contain Ȃ1.5 g (60 IU) per 100 kcal in the NNDB (24) . These levels are close to the midpoint in the range that the FDA regulations have established for commercially available infant formula, which must contain between 1 g (40 IU) and 2.5 g (100 IU) of vitamin D per 100 kcal (25) .
The accuracy of label information on the vitamin D content of infant formulas is controversial. A 1992 publication suggested that the vitamin D content of 7 of 10 commercial infant formulas exceeded label declarations by 200%, with one product containing 400% of its label value (26 
Vitamin D content of dietary supplements
Since 1988, NHANES has collected label information on dietary supplements, including vitamin D, used by study participants (11) (12) (13) (14) 18 ). An ongoing study is developing a dietary supplement composition database that will provide analyzed values for selected nutrients in the top marketed multivitaminmineral supplement products (29 -31) . A standard reference material for fat-soluble and other nutrients in a multivitaminmineral dietary supplement will soon be available (32) .
Traditionally, many marketed dietary supplements contained 400 IU per daily dose. The form of vitamin D used in supplement products can be either vitamin D 2 or vitamin D 3 . A quick scan of currently marketed products suggests that some manufacturers are switching their vitamin D source from vitamin D 2 to vitamin D 3 and some are increasing the vitamin D content of their products (eg, from 400 to 800 IU or more per day).
Label values as surrogates for vitamin D content
In the absence of analyzed values for the vitamin D content of foods and supplements, label declarations of amounts of vitamin D are often used as surrogates of vitamin D content. In the United States, label values that comply with FDA regulations generally underestimate the actual amount of vitamin D (or any other vitamin) because they must reflect the minimum amount of vitamin D in the product throughout its shelf life (18) . To ensure that their products meet FDA regulatory requirements, manufacturers tend to add overages to fortified foods. A dietary supplement trade association recently suggested that manufacturers of dietary supplements add overages of Ȃ30 -50% of vitamin D 2 and 30% of vitamin D 3 to dietary supplement products (18) . For naturally occurring sources of vitamin D in foods, manufacturers must declare the minimum level after taking into account shelf life losses and natural variabilities in content. Because other countries (eg, in Europe, Canada) require that manufacturers base label nutrient declarations on means rather than minimums, the meaning of label declarations varies from country to country.
The accuracy of label declarations of vitamin D in foods is also uncertain because of the paucity of validated analytic methods for a broad range of food matrices and the absence of standard reference materials for analyzing the vitamin D content of foods, except for milk-based infant formulas (33, 34) . In 1992, Holick et al (26) reported that only 29% of 42 milk samples contained 80-120% of the vitamin D label declaration, 62% of the milk samples contained 80% of the claimed label value, and 3 of 14 samples of skim milk contained no detectable vitamin D. Tanner et al (35) suggested that the decreasing adherence to the label claim with decreasing fat content in fortified milks in the 1980s could have been due to methods and stage of vitamin addition before processing. More recently, a 4-y survey of fluid milks in New York suggested that approximately half complied with label declarations (36) . Most milk samples that were out of compliance were underfortified, and the content of slightly 20% of underfortified products was within 20% of the label claim, although vitamin D concentrations did not vary by milk fat content.
Given the uncertainties about the accuracy of analytic methods, the lack of standard reference materials for most food matrices, the incompleteness of fortification data on nationally representative food products, and the dated nature of many of the published analytic results, determining the usefulness of vitamin D label values for estimating intakes remains difficult.
Intake data
Because of unresolved problems in obtaining accurate and complete information on the vitamin D content of foods, the USDA did not include vitamin D composition data from the NNDB when they developed the survey food-composition files for the 1999 to the current NHANES. NHANES III (1988 -1994) , which used vitamin D composition data from the University of Minnesota database, is the only national survey database that provides information on the vitamin D content of foods as part of the survey documentation (Table 1; 7) .
Calvo et al (10) estimated vitamin D intakes for US population groups by using the NHANES III (1988 -1994) data. They applied statistical adjustments to estimate usual intakes and to account for the complex sampling design used in NHANES. This survey is dated, the adequacy of the composition databases is uncertain, and dietary intakes generally tend to have an underreporting bias (37, 38) ; however, the NHANES III data can provide useful information on relative differences among subgroups and underscore the importance of including dietary supplement use in estimates of total intakes. Calvo et al found that males generally had a higher intake than did females ( Table 2) . Moore et al (39) , also using the NHANES III survey, found that total intake of vitamin D was lowest in females aged 14 -30 y and highest in children aged 1-8 y. Estimates from a later NHANES (1999 -2000) in which the authors updated earlier vitamin D composition files, suggested that females aged ͧ51 y had the highest total intake (9.5 Ȁ 0.4 g/d, or 380 Ȁ 16 IU) and females aged 9 -18 y had the lowest total intake [5.6 Ȁ 0.3 g/d, or 224 Ȁ 12 IU (40)]. In both NHANES III (1988 -1994) and the 1999 -2000 NHANES surveys, non-Hispanic whites generally had a higher intake than did non-Hispanic blacks and MexicanAmericans (Table 2 ; 10, 40). Estimated mean total intakes (from foods and supplements) were Ȃ20-40% higher than mean intakes from foods alone in NHANES III (10) . In general, means were higher than medians for all groups. This suggests a significant skew to the intake distributions and indicates that some persons had a relatively high total intake (10).
Prevalence of supplement use
Because dietary supplements contain relatively large amounts of nutrients in concentrated form, supplement use can markedly affect total intakes of micronutrients. NHANES has collected information on dietary supplement use and label declarations of nutrient content since 1988 (Table 1) . Over time, dietary supplement use has increased among adults (12) but has remained relatively constant or declined in children; declines are most pronounced in younger children (11) . Multivitamin-multimineral supplements are the most common supplement product consumed by both adults and children.
In NHANES 1999 -2002, the percentage of children taking vitamin D-containing supplements ranged from 9% for children younger than 1 y to 36% for children aged 4 -8 y (11). The prevalence of vitamin D supplement use was 33% in children aged 1-3 y, 23% in those aged 9 -13 y, and 16% in adolescents aged 14 -18 y. Overall, males and females had a similar prevalence of use (25% of males and 27% of females). Non-Hispanic white children had a higher prevalence of use (31%) than did non-Hispanic black (16%) and Mexican American children (19%). Children classified as being underweight or at risk of underweight had a higher prevalence of use of vitamin D-containing supplements (30% for underweight children, 32% for children at risk of underweight) than did children classified as probably being at a healthy weight (28%), at risk of overweight (23%), or overweight (20%).
Radimer et al (12) published results on the prevalence of multivitamin-multimineral supplement use in adults from NHANES 1999 -2000 but did not provide specific information on the use of vitamin D-containing dietary supplements. They reported a prevalence of multivitamin-multimineral use of 32% in males and 38% in females. Multivitamin-multimineral use increased with age from 30% for adults aged 20 -39 y to 40% for adults aged ͧ60 y. As with children, a larger percentage of non-Hispanic white adults (40%) than non-Hispanic blacks (23%) or Mexican Americans (20%) used multivitaminmultimineral supplements. Similarly, leaner adults were more likely to use multivitamin-multimineral supplements than were obese adults [40% among those with a body mass index (BMI; in 
VITAMIN D STATUS

NHANES collects and analyzes biomarkers and clinical mea-
EVALUATING SUFFICIENCY
I have described the available data and selected results from the NNMS that are relevant to evaluating the vitamin D nutritional status of US population groups. I have attempted to follow the approaches that expert panels (1) identified; these approaches emphasized the need to consider both data quality and interpretability issues when using the NNMS data for assessing the nutritional status of the US population. Current evaluations of the vitamin D status of US population groups warrant caution due to uncertainties regarding the completeness, measurement techniques, and interpretability of currently available dietary and biomarker status measures.
The use of 25(OH)D concentrations as a biomarker of vitamin D exposure and status is common (23, 44) . 25(OH)D concentrations reflect the net effects of cutaneous synthesis from sun exposure and oral intake from food and supplement sources, with correction for potential differences in the bioavailability and bioequivalence of these different sources and differences in skin bioconversion rates. However, scientists should be cautious when interpreting data on 25(OH)D concentrations, because laboratory methods lack standardization (44, 47, 48) . Even the subtle methodologic drift that occurred when CDC used the DiaSorin radioimmunoassay for analyzing NHANES 25 (42) . Because of the lack of randomized clinical trials in other age and life-stage groups, several researchers have used results from crosssectional and cohort observational studies to suggest that a similar threshold 25(OH)D concentration is useful for identifying vitamin D insufficiency in younger adults (50) . However, a recent systematic review concluded that, although fair evidence exists for an association between circulating 25(OH)D concentrations and some bone health outcomes (established rickets, parathyroid hormone concentration, falls, and bone mineral density), defining specific thresholds of circulating 25(OH)D for optimal bone health is difficult because of the imprecision of different 25(OH)D assays (51) .
Noting these types of uncertainties, a scientific advisory committee commissioned by several UK government agencies concluded in a recent position paper that the current data are insufficient to clarify relations among vitamin D intake, biochemical status, and chronic disease outcomes (44) . Specifically, they noted the complex interactions among dietary calcium intake, parathyroid hormone concentrations, renal function, and turnover of vitamin D metabolites, as well as the variable effects of age and other factors on these interrelations. Thus, controversy currently exists with regard to interpretive criteria for 25(OH)D concentrations across the life cycle and among subgroups.
Interpreting data on 25(OH)D concentrations for obese and overweight persons is particularly challenging. The NHANES showed lower circulating concentrations of 25(OH)D among young adult obese non-Hispanic white women than their leaner counterparts (8, 45) . Differences in physical activity partially explained these differences, but the relations appeared to be weaker among non-Hispanic blacks than non-Hispanic whites. Some of these differences might be due to physiologic factors. Obese persons had lower circulating 25(OH)D concentrations than did leaner persons after supplementation with vitamin D 2 and after exposure to ultraviolet radiation (52) . However, overweight and obese persons in NHANES also reported lower use of multivitamin-multimineral supplements and vitamin D-containing dietary supplements than did leaner persons of the same age or sex group (11) (12) ; these results suggest that low dietary exposures could also contribute to the lower 25(OH)D concentrations in overweight and obese people. The 2007 UK advisory committee report cited a need to better understand the effects of adiposity on circulating 25(OHD) concentrations and the implications of the relation between adiposity and 25(OH)D concentrations for vitamin D requirements (44) .
Limited information is available on the vitamin D intakes of US population groups because of the incomplete information on the vitamin D content of foods currently available, the lack of validated analytic methods for a wide range of food matrices (33) , and the absence of standard reference materials for ensuring the accuracy of analytic results (34) . Monitoring vitamin D intakes from dietary supplements is somewhat easier because a 
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YETLEY composition database is available that contains label information collected since 1988 on the vitamin D content of supplements used by NHANES participants (11) (12) (13) (14) . The quality of the information on the vitamin D content of marketed dietary supplements should soon improve with the availability of a standard reference material for analyzing vitamin D content in dietary supplements (32) and with the results of an upcoming analysis of the vitamin D content of 35 top dietary supplement multivitaminmultimineral products (29 -31) .
Given the concerns about data quality and interpretability of status measures, comparisons of survey results against predetermined cutoffs to assess the adequacy of intakes and of 25(OH)D concentrations require multidisciplinary discussions and expertise that are beyond the scope of this article. However, comparisons of relative differences among subgroups could be informative because common measurement tools are used across the groups being compared. Males of all age groups generally had a higher 25(OH)D concentration and a slightly higher total intake of vitamin D (foods plus supplements) than did females. Children had the lowest prevalence of low 25(OH)D concentrations and children aged 6 -11 y had a higher total intake (foods plus supplements) than did older children or adults. Children aged 4 -8 y also had higher dietary supplement use than did children of other ages. Supplement use was 30% in adults aged 20 -39 y and 40% in adults aged ͧ60 y; total intake tended to be slightly higher in older adults than in younger adults. However, the prevalence of serum 25(OH)D concentrations of 50 nmol/L was relatively stable across all adults aged ͧ20 y. Relative differences among racial and ethnic groups tended to be consistent across the different measures of vitamin D status. In general, non-Hispanic whites had higher 25(OH)D concentrations, dietary intake, and dietary supplement use than did Mexican Americans and nonHispanic blacks.
SUMMARY
In this article, I identified the information in the NNMS that scientists can use to assess the vitamin D status of US population groups and described the strengths and weaknesses of the available data. Because of limitations in data quality, completeness, and interpretability, determining the proportion of the US population that is vitamin D sufficient is complex and controversial. A recent advisory committee report from the United Kingdom did not recommend changing the traditional 25(OH)D concentration cutoffs for vitamin D sufficiency due to the uncertainties and inconsistencies in the current evidence. Conversely, several researchers recently proposed significant changes to the criteria for determining vitamin D status. The numerous uncertainties in evaluating the vitamin D status of US population groups will benefit from further dialogue among a broad range of qualified experts, including experts in vitamin D metabolism, nutritional assessment across the life cycle and during pregnancy and lactation, biostatics, and various chronic diseases. The author had no conflicts of interest.
